SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Paracelsian Inc (PRLN)
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Rick Costantino who wrote (386)9/5/1996 8:22:00 PM
From: WWS   of 4342
 
Rick, new AIDS drugs can get "accelerated" approval by FDA. Merck's protease inhibitor was approved just 42 days after application to FDA. Their application was based on just two clinical trial involving less than 500 patients. If PN355 is an effective, safe, and cheap treatment it could, in theory, be approved just as quickly. The URL for the Merck protease inhibitor follows pharminfo.com Best regards, Bill in St. Louis.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News